Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Discover Oncology|February 23, 2023
Transcriptomic analysis predicts the risk of progression of premalignant lesions in human tongueTuo Zhang, David Kutler, Theresa Scognamiglio, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2018
A Retinoic Acid β2-Receptor Agonist Exerts Cardioprotective EffectsAlice Marino, Takuya Sakamoto, Xiao-Han Tang, et al.
Pharmacology|May 13, 2022
Fenretinide Reduces Intestinal Mucin-2-Positive Goblet Cells in Chronic Alcohol AbuseMarta Melis, Xiao-Han Tang, Karen Mai, et al.
Frontiers in Pharmacology|April 5, 2021
Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver DiseaseXiao-Han Tang, Marta Melis, Karen Mai, et al.
Cancer Biology & Therapy|February 11, 2020
Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinomaJocelin M Kalish, Xiao-Han Tang, Theresa Scognamiglio, et al.
Oncotarget|February 26, 2015
Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis modelKwame Osei-Sarfo, Alison M Urvalek, Xiao-Han Tang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|August 17, 2021
[An integrative metabolomics and network pharmacology method for exploring bioactive components and preliminary pharmacodynamics in medicinal parts of Harrisonia perforata]Xin-Meng Wang, Xiao-Han Tang, Ying-Yao Li, et al.
Cancer Research Communications|December 12, 2025
Key early changes in oral squamous cell carcinogenesis are accelerated by ectopic BMI1 expressionJorge Baquero, Xiao-Han Tang, Daniel Galke, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 29, 2018
Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor β2 AgonistSteven E Trasino, Xiao-Han Tang, Maria M Shevchuk, et al.
Pageof 6